Barinthus Biotherapeutics Plc (BRNS)
0.7401
-0.02
(-2.49%)
USD |
NASDAQ |
Sep 08, 16:00
0.7628
+0.02
(+3.07%)
After-Hours: 20:00
Barinthus Biotherapeutics Enterprise Value : -19.04M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | -19.04M |
| September 04, 2026 | -18.27M |
| September 03, 2026 | -19.89M |
| September 02, 2026 | -18.92M |
| September 01, 2026 | -18.02M |
| August 31, 2026 | -20.80M |
| August 28, 2026 | -18.79M |
| August 27, 2026 | -19.41M |
| August 26, 2026 | -20.42M |
| August 25, 2026 | -22.31M |
| August 24, 2026 | -24.64M |
| August 21, 2026 | -23.88M |
| August 20, 2026 | -24.26M |
| August 19, 2026 | -24.67M |
| August 18, 2026 | -23.95M |
| August 17, 2026 | -25.03M |
| August 14, 2026 | -25.13M |
| August 13, 2026 | -24.77M |
| August 12, 2026 | -25.48M |
| August 11, 2026 | -25.78M |
| August 10, 2026 | -26.31M |
| August 07, 2026 | -24.81M |
| August 06, 2026 | -26.19M |
| August 05, 2026 | -25.99M |
| August 04, 2026 | -26.21M |
| Date | Value |
|---|---|
| August 03, 2026 | -24.77M |
| July 31, 2026 | -26.49M |
| July 30, 2026 | -26.52M |
| July 29, 2026 | -25.84M |
| July 28, 2026 | -25.99M |
| July 27, 2026 | -24.72M |
| July 24, 2026 | -24.68M |
| July 23, 2026 | -24.76M |
| July 22, 2026 | -24.76M |
| July 21, 2026 | -24.52M |
| July 20, 2026 | -24.07M |
| July 17, 2026 | -26.58M |
| July 16, 2026 | -21.91M |
| July 15, 2026 | -22.53M |
| July 14, 2026 | -24.27M |
| July 13, 2026 | -24.36M |
| July 10, 2026 | -23.22M |
| July 09, 2026 | -23.22M |
| July 08, 2026 | -23.24M |
| July 07, 2026 | -23.58M |
| July 06, 2026 | -23.52M |
| July 02, 2026 | -23.94M |
| July 01, 2026 | -23.09M |
| June 30, 2026 | -22.31M |
| June 29, 2026 | -29.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.62M |
| Total Expenses (Quarterly) | 10.60M |
| EPS Diluted (Quarterly) | -0.2595 |
| Earnings Yield | -138.1% |
| Normalized Earnings Yield | -110.21 |